Results 161 to 170 of about 71,512 (251)

Treatment of Burkitt lymphoma in real-world setting: findings on 104 consecutive cases diagnosed and treated in Kazakhstan over the last decade. [PDF]

Ann Hematol
Jazyltayeva A, Shokun N, Umutbayeva A, Conte L, Ramazanova R, Kemaikin V, Karabekov A, Shalabay A, Koshkarbayeva A, Kemelbekov N, Zhumabay M, Shokubayeva F, Stepanihyna Y, Federico M, Gabbasova S.   +14 more
europepmc   +1 more source

A Rare Presentation of Alveolar Rhabdomyosarcoma of the Sinonasal and Nasopharyngeal Region With Bone Marrow Metastasis. [PDF]

Cureus
Al Tatari M, Ramirez J, Hernandez S, Martinez E, Casadesus D.   +4 more
europepmc   +1 more source

Comedication that increase the risk of cisplatin-induced hearing loss in pediatric cancer patients: a narrative literature review and meta-analysis. [PDF]

Front Oncol
de Jager KE, Streefkerk N, Hoetink AE, van Tinteren H, van Grotel M, van den Heuvel-Eibrink MM.   +5 more
europepmc   +1 more source

Response to the Letter to the Editor Entitled "Revisiting Vincristine for FSGS: Proof-of-Mechanism Arrives, but Whom Should we Treat?" [PDF]

Kidney Int Rep
Mason WJ, Chandler JC, Gage AM, Pomeranz G, Price KL, Antonelou M, Henderson SR, Perin L, Da Sacco S, Salama AD, Long DA, Pepper RJ.   +11 more
europepmc   +1 more source

Hodgkin lymphoma: EHA Clinical Practice Guidelines for diagnosis, treatment, and follow‐up

HemaSphere, Volume 10, Issue 6, June 2026.
Abstract Hodgkin lymphoma (HL) is a B‐cell‐derived malignancy often affecting young adults. Allocation into risk groups is based on staging with positron emission tomography and computed tomography (PET/CT) and the presence or absence of risk factors.
Dennis A. Eichenauer, Marc André, Peter Borchmann, Graham P. Collins, Ian Doherty, Hans‐Theodor Eich, Massimo Federico, Alexander Fossa, Sylvia Hartmann, Martin Hutchings, Timothy Illidge, Carsten Kobe, Wouter J. Plattel, Lena Specht, Anna Sureda, Jan M. Zaucha, Joseé M. Zijlstra, Igor Aurer   +17 more
wiley   +1 more source

Single-center analysis of relapse risk factors and prognosis in 256 cases of ETV6::RUNX1-positive pediatric acute lymphoblastic leukemia. [PDF]

BMC Pediatr
Hu B, Hu F, He H, Kong L.
europepmc   +1 more source

Assessment of Potential Sources of Variability on the Analytical Performance of a Circulating Tumor DNA Minimal Residual Disease Test for B‐Cell Lymphomas

Journal of Clinical Laboratory Analysis, Volume 40, Issue 11, June 2026.
Laboratory tests must exhibit robustness to common sources of test variability, particularly for tests with the potential to inform treatment decisions. This study presents data that shows that a phased variant enrichment and detection sequencing (PhasED‐Seq)‐based circulating tumor DNA minimal residual disease (ctDNA‐MRD) test is robust, with results ...
Nina Klimova, Alanna Roff, Justine McCutcheon, Alex Aheimer, Sandra L. Close, Richard D. Hockett, Stephanie Meek, Laura Hyland   +7 more
wiley   +1 more source

Combinatorial chemistry identifies additional compounds that selectively inhibit DLK-dependent retrograde signaling while minimally affecting other axonal roles of DLK. [PDF]

Sci Rep
Zhang X, Jeong H, Melenski E, Gordon J, Childers WE, Thomas GM.   +5 more
europepmc   +1 more source

Tumour‐Derived Extracellular Vesicles Induce Diffuse Large B‐Cell Lymphoma Progression Through Macrophage‐Mediated MDSC Accumulation

Journal of Extracellular Vesicles, Volume 15, Issue 6, June 2026.
ABSTRACT Elevated peripheral myeloid‐derived suppressor cells (MDSCs) predicted suppressed anti‐tumour immunity and poor prognosis in diffuse large B‐cell lymphoma (DLBCL) patients. Here we demonstrated that tumour‐derived extracellular vesicles (EVs) served as a messenger, delivering cholesterol from lymphoma cells to macrophages.
Mengke Liu, YingYu Dong, Qixiao Guan, JianBiao Wang, Qing Shi, RongGui Lin, Muchen Zhang, Di Fu, Shu Cheng, Pengpeng Xu, Eurydice Angeli, Guilhem Bousquet, Wenguo Cui, Hongjing Dou, Wei‐Li Zhao, Li Wang   +15 more
wiley   +1 more source